Company Filing History:
Years Active: 2024
Title: Innovations by Harry An in PBMC Formulations
Introduction
Harry An is an accomplished inventor based in Watertown, MA (US). He has made significant contributions to the field of biomedical research, particularly in the formulation of modified peripheral blood mononuclear cells (PBMCs). His work is crucial for advancements in immunotherapy and vaccine development.
Latest Patents
Harry An holds a patent for formulations of PBMCs. The patent details formulations that include PBMCs comprising at least one antigen, such as a human papillomavirus (HPV) antigen, along with a cryopreservation medium. In certain embodiments, the PBMCs are conditioned by incubating them in the presence of an adjuvant, enhancing their efficacy for therapeutic applications.
Career Highlights
Harry An is currently employed at Stemcell Technologies Canada Inc., where he continues to innovate in the field of cell therapy. His expertise in PBMC formulations has positioned him as a key player in the development of new therapeutic strategies.
Collaborations
Harry has collaborated with notable colleagues, including Howard Bernstein and Scott Loughhead. Their combined efforts contribute to the advancement of research in cellular therapies and immunology.
Conclusion
Harry An's work in the formulation of PBMCs represents a significant advancement in biomedical research. His contributions are paving the way for new therapeutic options in the treatment of various diseases.